logo
header-image

Psychopharmacology and Psychiatry Updates

by Psychopharmacology Institute
139 EPISODES
Yesterday
All Episodes
Beyond Black Box Warnings: Choosing Antipsychotics in Dementia
Psychopharmacology Institute
SSRIs and Psychedelics: Drug Interactions
Psychopharmacology Institute
Standard vs. High Doses: Rethinking Bipolar Maintenance Treatment
Psychopharmacology Institute
Psychedelics and Brain Networks
Psychopharmacology Institute
LAIs vs Oral Antipsychotics: Mortality Data and Clinical Impact
Psychopharmacology Institute
The Science Behind Psychedelic Therapy
Psychopharmacology Institute
Which Antidepressant Causes the Most Weight Gain?
Psychopharmacology Institute
Lisdexamfetamine for Binge Eating Disorder
Psychopharmacology Institute
Beyond Weight Loss: GLP-1 Agonists and Alcohol Use Disorder
Psychopharmacology Institute
Antidepressants vs. Anticonvulsants for Binge Eating
Psychopharmacology Institute
Lithium Levels: Finding the Right Therapeutic Target
Psychopharmacology Institute
Antidepressants Beyond Depression: Applications in Bulimia Nervosa
Psychopharmacology Institute
Metformin and Antipsychotic-Induced Weight Gain: An Evidence-Based Solution
Psychopharmacology Institute
Monthly Injections, Long-Term Recovery: Naltrexone for OUD
Psychopharmacology Institute
Antipsychotics and Aspiration Risk
Psychopharmacology Institute
Buprenorphine, Methadone, and Naltrexone: Helping Patients with OUD Decide
Psychopharmacology Institute
Managing OUD with Buprenorphine: Clinical Pearls
Psychopharmacology Institute
Valproate Weight Gain: Do Lower Doses Help?
Psychopharmacology Institute
Methadone for Opioid Use Disorder
Psychopharmacology Institute
Clozapine and Compulsions: New Research On An Old Side Effect
Psychopharmacology Institute
Naltrexone vs. Topiramate: FDA-Approved vs. Off-Label Options for MAUD
Psychopharmacology Institute
Beyond Tapering: Supporting Patients Through Benzodiazepine Discontinuation
Psychopharmacology Institute
Beyond Blood Counts: Clozapine, Bowel Obstruction, and Pneumonia
Psychopharmacology Institute
Demystifying Benzodiazepine Deprescribing: Smart Approaches to Tapering
Psychopharmacology Institute
Lithium: Implications for Bone Health
Psychopharmacology Institute
Tapering with Care: Benzodiazepine Discontinuation
Psychopharmacology Institute
Dementia Risk and Vitamin D
Psychopharmacology Institute
Beyond Benzos: Strategies for Successful Deprescribing
Psychopharmacology Institute
Motherhood and Medication: LAIs for Women with Schizophrenia
Psychopharmacology Institute
Benzodiazepines in High-Risk Populations
Psychopharmacology Institute
Benzodiazepines: Understanding Physical Dependence vs. Addiction
Psychopharmacology Institute
Beyond Metformin: Probiotics and Antipsychotic Weight Gain
Psychopharmacology Institute
What Every Clinician Should Know About the Risks of Benzodiazepines
Psychopharmacology Institute
Making an Exit Plan: Navigating Antidepressant Discontinuation
Psychopharmacology Institute
Clinical Pearls for Selecting the Right Benzodiazepine
Psychopharmacology Institute
TMS for Depression: From Clinical Trials to Results
Psychopharmacology Institute
A Guide to Selecting TMS Candidates
Psychopharmacology Institute
Rethinking Clozapine Monitoring: 22 Years of Data
Psychopharmacology Institute
Understanding TMS in OCD: Evidence and Practice
Psychopharmacology Institute
Breaking Down the TRAILBLAZER-ALZ 2 Trial
Psychopharmacology Institute
Long-term Benzo Use: What The Data Really Show
Psychopharmacology Institute
Navigating TMS Side Effects: A Practical Guide
Psychopharmacology Institute
SSRIs and Anticoagulants: Navigating Bleeding Risk
Psychopharmacology Institute
Lamotrigine and the Heart: What You Need to Know
Psychopharmacology Institute
After the Last Dose: Understanding Antipsychotic Discontinuation
Psychopharmacology Institute
Understanding Lamotrigine's Cardiac Effects
Psychopharmacology Institute
Rethinking Falls: Are Sleep Medications Really to Blame?
Psychopharmacology Institute
Navigating Lamotrigine's Side Effects
Psychopharmacology Institute
Iloperidone in Bipolar Disorder: A New Treatment Option?
Psychopharmacology Institute
Lamotrigine: Pearls for Prescribing
Psychopharmacology Institute